NEW YORK, Jan 25, 2026, 11:19 AM EST — Market closed.
- JPMorgan raised its price target for Procter & Gamble, joining Wells Fargo and UBS in boosting their own estimates.
- PG shares closed Friday at $150.15, with U.S. markets offline for the weekend.
- This week’s Fed decision and crucial consumer data have investors focused on what’s next.
JPMorgan lifted Procter & Gamble to Overweight from Neutral, boosting its price target to $165 from $157, TheFly reports. P&G shares closed Friday at $150.15, up 0.15%, and will resume trading when markets open Monday.
The timing is crucial. P&G remains a core holding for numerous funds, often drawing capital from investors seeking reliable earnings—even if growth tapers off.
The quarter revealed a clear tension within the business — prices stayed firm, but demand weakened. P&G reported “organic sales” — which exclude currency effects and acquisitions or divestitures — were flat. Core earnings per share, adjusted for one-time items, came in at $1.88. CEO Shailesh Jejurikar confirmed the company is still on track to meet its fiscal-year guidance. Procter & Gamble
JPMorgan analyst Andrea Teixeira expects P&G to pick up organic sales growth and boost margins, saying the “worst seems behind” following increased investment. She added, “We give PG the benefit of the doubt,” though she warned of execution risks tied to regaining market share. Investors.com
Wells Fargo’s Chris Carey bumped his price target on Procter & Gamble to $165 from $158, maintaining an Overweight rating. Carey noted, “If U.S. data improves, Procter & Gamble works,” highlighting the “if” as the key uncertainty. TipRanks
UBS bumped its price target to $170 from $161 and stuck with a Buy rating, noting that P&G beat estimates in the second quarter while maintaining its fiscal 2026 guidance.
In its latest quarterly filing, P&G revealed it repurchased around $2.3 billion in shares and paid a dividend of $1.0568 per share. The company also flagged tariff expenses and product mix as headwinds impacting gross margin in certain segments.
Traders are now eyeing whether the stock can stay above $150 without a new catalyst. P&G’s lineup — including Tide, Pampers and Gillette — is closely tied to consumer behavior, and its pricing and volume trends could ripple through peers like Kimberly-Clark, Colgate-Palmolive and Unilever.
The boost from upgrades could vanish quickly if U.S. consumer spending remains weak, retailers resist raising prices, or costs surge again. Rising rates wouldn’t offer relief either; dividend-heavy defensive stocks tend to stumble as bond yields climb.
The key event this week is the Federal Reserve’s policy announcement on Wednesday, Jan. 28, set for 2 p.m. ET, followed by Chair Jerome Powell’s press briefing at 2:30 p.m. ET. On Tuesday, the U.S. consumer confidence report drops at 10 a.m. ET.
